These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 29091198)
1. CD4 cell count response to first-line combination ART in HIV-2+ patients compared with HIV-1+ patients: a multinational, multicohort European study. Wittkop L; Arsandaux J; Trevino A; Schim van der Loeff M; Anderson J; van Sighem A; Böni J; Brun-Vezinet F; Soriano V; Boufassa F; Brockmeyer N; Calmy A; Dabis F; Jarrin I; Dorrucci M; Duque V; Fätkenheuer G; Zangerle R; Ferrer E; Porter K; Judd A; Sipsas NV; Lambotte O; Shepherd L; Leport C; Morrison C; Mussini C; Obel N; Ruelle J; Schwarze-Zander C; Sonnerborg A; Teira R; Torti C; Valadas E; Colin C; Friis-Møller N; Costagliola D; Thiebaut R; Chene G; Matheron S; J Antimicrob Chemother; 2017 Oct; 72(10):2869-2878. PubMed ID: 29091198 [TBL] [Abstract][Full Text] [Related]
2. Recent trends in early stage response to combination antiretroviral therapy in Australia. McManus H; Hoy JF; Woolley I; Boyd MA; Kelly MD; Mulhall B; Roth NJ; Petoumenos K; Law MG; Antivir Ther; 2015; 20(2):131-9. PubMed ID: 24704818 [TBL] [Abstract][Full Text] [Related]
3. Plasma HIV-2 RNA According to CD4 Count Strata among HIV-2-Infected Adults in the IeDEA West Africa Collaboration. Ekouévi DK; Avettand-Fènoël V; Tchounga BK; Coffie PA; Sawadogo A; Minta D; Minga A; Eholie SP; Plantier JC; Damond F; Dabis F; Rouzioux C; PLoS One; 2015; 10(6):e0129886. PubMed ID: 26111242 [TBL] [Abstract][Full Text] [Related]
4. Response to zidovudine/didanosine-containing combination antiretroviral therapy among HIV-1 subtype C-infected adults in Botswana: two-year outcomes from a randomized clinical trial. Bussmann H; Wester CW; Thomas A; Novitsky V; Okezie R; Muzenda T; Gaolathe T; Ndwapi N; Mawoko N; Widenfelt E; Moyo S; Musonda R; Mine M; Makhema J; Moffat H; Essex M; Degruttola V; Marlink RG J Acquir Immune Defic Syndr; 2009 May; 51(1):37-46. PubMed ID: 19282782 [TBL] [Abstract][Full Text] [Related]
5. Reference curves for CD4 T-cell count response to combination antiretroviral therapy in HIV-1-infected treatment-naïve patients. Bouteloup V; Sabin C; Mocroft A; Gras L; Pantazis N; Le Moing V; d'Arminio Monforte A; Mary-Krause M; Roca B; Miro JM; Battegay M; Brockmeyer N; Berenguer J; Morlat P; Obel N; De Wit S; Fätkenheuer G; Zangerle R; Ghosn J; Pérez-Hoyos S; Campbell M; Prins M; Chêne G; Meyer L; Dorrucci M; Torti C; Thiébaut R; HIV Med; 2017 Jan; 18(1):33-44. PubMed ID: 27625009 [TBL] [Abstract][Full Text] [Related]
6. Short-term and long-term clinical and immunological consequences of stopping antiretroviral therapy in HIV-infected patients with preserved immune function. Imaz A; Olmo M; Peñaranda M; Gutiérrez F; Romeu J; Larrousse M; Domingo P; Oteo JA; Curto J; Vilallonga C; Masiá M; López-Aldeguer J; Iribarren JA; Podzamczer D; Antivir Ther; 2013; 18(1):125-30. PubMed ID: 22805174 [TBL] [Abstract][Full Text] [Related]
7. Absence of effect of menopause status at initiation of first-line antiretroviral therapy on immunologic or virologic responses: a cohort study from Rio de Janeiro, Brazil. Calvet GA; Velasque L; Luz PM; Cardoso SW; Derrico M; Moreira RI; de Andrade AC; Cytryn A; Pires E; Veloso VG; Grinsztejn B; Friedman RK PLoS One; 2014; 9(2):e89299. PubMed ID: 24586673 [TBL] [Abstract][Full Text] [Related]
8. CD4+ T cell count recovery in HIV type 1-infected patients is independent of class of antiretroviral therapy. Khanna N; Opravil M; Furrer H; Cavassini M; Vernazza P; Bernasconi E; Weber R; Hirschel B; Battegay M; Kaufmann GR; Clin Infect Dis; 2008 Oct; 47(8):1093-101. PubMed ID: 18783328 [TBL] [Abstract][Full Text] [Related]
9. Estimated average annual rate of change of CD4(+) T-cell counts in patients on combination antiretroviral therapy. Mocroft A; Phillips AN; Ledergerber B; Smith C; Bogner JR; Lacombe K; Wiercinska-Drapalo A; Reiss P; Kirk O; Lundgren JD; Antivir Ther; 2010; 15(4):563-70. PubMed ID: 20587849 [TBL] [Abstract][Full Text] [Related]
10. Prognosis of patients treated with cART from 36 months after initiation, according to current and previous CD4 cell count and plasma HIV-1 RNA measurements. ; Lanoy E; May M; Mocroft A; Phillip A; Justice A; Chêne G; Furrer H; Sterling T; Monforte AD; Force L; Gill J; Harris R; Hogg RS; Rockstroh J; Saag M; Khaykin P; de Wolf F; Sterne JA; Costagliola D AIDS; 2009 Oct; 23(16):2199-208. PubMed ID: 19779320 [TBL] [Abstract][Full Text] [Related]